The road for developing new pharmacological therapies for Parkinson's disease: Current trends and targets in clinical trials.

BackgroundDespite substantial research efforts, advances in Parkinson's disease therapeutics remain largely confined to the management of motor symptoms, with comparatively limited progress in addressing non-motor features, and with no proven success…

Preview only. Read the full abstract at the source